Based on its unique microsphere technology Nasus Pharma is developing a number of intranasal powder products aimed at assisting patients in several acute emergency situations.
Intranasal administration is most suitable for those situations in which rapid drug delivery is required and offers multiple advantages such as rapid drug delivery, ease of use, non-invasiveness, and safety. Intranasal administration bypasses the massive liver metabolism and can deliver drugs directly to the brain (nose to brain). It enables rescue of patients by caregivers and non-professional personnel and has the potential to save lives in life-threatening situations where prompt treatment is critical.
Intranasal powder drug delivery has an inherent advantage over solutions due to the higher dispersion of the drug particles in the nasal cavity.
Nasus powder technology was tested in clinical studies and proved to be superior to a similar solution based drug:
- 7 times higher absorption in the first 4 minutes.
- 4 times higher absorption in the first 10 minutes.
These advantages have the potential to save lives!
Nasus’s founders and top management have an impressive track record in building Pharma companies, and enhancing value for patients; caretakers and investors.